SURPASS trial programme: difference between revisions
Diff·revision 13 → 14·14:17, 23 Jan 2025
Difference between revision 13 and revision 14 of SURPASS trial programme. 2 lines changed; the page grew by 184 bytes.
| Revision 13 — 17:13, 4 Jan 2025 DataTableDunja (talk) name the funder in the sentence, per PP:MOS 3,774 bytes ±0 | Revision 14 — 14:17, 23 Jan 2025 SurmountSurma (talk) British spelling per PP:MOS 3,958 bytes +184 | ||
|---|---|---|---|
| 32 | The result is a genuine head-to-head at the doses studied, and the doses studied were the approved diabetes doses of both agents at the time. It is not a comparison of maximal doses, and it is not evidence about the obesity indication, where the relevant comparison is between [[SURMOUNT trial programme|SURMOUNT]] and [[STEP trial programme|STEP]] — which are separate trials in separate populations and therefore not a head-to-head at all.{{r|jastreboff2022}} | 32 | The result is a genuine head-to-head at the doses studied, and the doses studied were the approved diabetes doses of both agents at the time. It is not a comparison of maximal doses, and it is not evidence about the obesity indication, where the relevant comparison is between [[SURMOUNT trial programme|SURMOUNT]] and [[STEP trial programme|STEP]] — which are separate trials in separate populations and therefore not a head-to-head at all.{{r|jastreboff2022}} |
| 33 | 33 | ||
| + | 34 | Cross-trial comparison of SURMOUNT-1 with STEP 1 is made constantly and is not sound: the populations, durations, escalation schedules and lifestyle interventions differ.{{r|ich_e9}} | |
| + | 35 | ||
| 34 | == References == | 36 | == References == |
| 35 | {{reflist}} | 37 | {{reflist}} |